Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Cookies
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Edwards Lifesciences
EW · NYSE · Health Care Equipment
$105.23−0.20 (−0.19%)
Close of Nov 18, 2026, vs Nov 17 · end-of-day, not a live quote
Edwards Lifesciences (EW) · oqro.io/stocks/EW · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
Traded May 27 · filed the same dayNot reported under a pre-arranged trading plan
Since the trade +21.6% · S&P 500 −2.7% · to Nov 18
Edwards Lifesciences's CVP,Strategy/Corp Development sold $2M of Edwards Lifesciences shares. The filing does not indicate a pre-arranged trading plan.
0 open-market purchases and 42 open-market sales by insiders of EW between Jan 11, 2026 and today, placed against the company's last 4 earnings releases. The latest on file was filed Nov 4, 2026. The data provider lists the next release for Feb 8, 2027; that date may change.
PurchaseSale30 days before a release30 days after
Trades in the 30 days around each of the last earnings releases
Daniel J. Lippis, CVP, TAVR, Nov 10, 2026, about $65K. Sold 6 days after the company's previous earnings release on 2026-11-04Form 4
Bernard J Zovighian, CEO, Nov 9, 2026, about $1.43M. Sold 5 days after the company's previous earnings release on 2026-11-04Form 4
Bernard J Zovighian, CEO, Nov 9, 2026, about $949K. Sold 5 days after the company's previous earnings release on 2026-11-04Form 4
Donald E Jr Bobo, CVP,Strategy/Corp Development, Nov 9, 2026, about $5.04M. Sold 5 days after the company's previous earnings release on 2026-11-04Form 4
Companies set trading windows, which usually close shortly before results and reopen after them, and insiders may trade under 10b5-1 plans adopted months earlier. A date alone does not show what a person knew or why they traded. Past release dates are the dates the company filed its 8-K with Item 2.02. An upcoming date, when one is mentioned, comes from the data provider's earnings calendar (Finnhub): it is not a company filing, it is not estimated by OQRO, and it may change. Open-market purchases and sales as reported on Form 4. Largest purchases around earnings, all companies
Daniel J. Lippis, CVP, TAVR, Oct 8, 2026, about $53K. Sold 27 days before the company's next earnings release on 2026-11-04